Dr Samuel Sherratt is the scientific director at Elucida Research in Beverly, MA (US). He is also a Visiting Professor at the Mount Sinai Fuster Heart Hospital at the Icahn School of Medicine in New York City, NY.
His research interests include elucidating novel mechanisms of action of omega-3 fatty acids, lipoprotein metabolism, endothelial cell function and disease pathophysiology, and X-ray diffraction analyses to evaluate drug interactions in membranes, among others.
Dr Sherratt has authored or co-authored 29 scientific research and review articles and more than 130 abstracts, which he has presented at national and international cardiology conferences. He received his B.S. in biology from Gordon College in 2015 and his Ph.D. in biochemistry from the University of New Hampshire in 2023.
